Evidence map›Paper›PMID 31072927›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Activation of PASK by mTORC1 is required for the onset of the terminal differentiation program.

Chintan K Kikani, Xiaoying Wu, Sarah Fogarty, Seong Anthony Woo Kang, Noah Dephoure, Steven P Gygi, David M Sabatini, Jared Rutter

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Structural assembly of the PAS domain drives the catalytic activation of metazoan PASK.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The Importance of mTORC1-Autophagy Axis for Skeletal Muscle Diseases.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Lysosomes at the Crossroads of Cell Metabolism, Cell Cycle, and Stemness.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Chintan K KikaniDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84132; chintan.kikani@utah.edu rutter@biochem.utah.edu.ORCID 0000-0003-1140-0192
Xiaoying WuDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84132.
Sarah FogartyDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84132.
Seong Anthony Woo KangWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Noah DephoureDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-5802-2657
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115.
David M SabatiniWhitehead Institute for Biomedical Research, Cambridge, MA 02142.ORCID 0000-0002-1446-7256
Jared RutterDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84132; chintan.kikani@utah.edu rutter@biochem.utah.edu.
University of Utah · USHarvard University · USBroad Institute · USHoward Hughes Medical Institute · USWhitehead Institute for Biomedical Research · US

Funding

TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
Metabolic regulation of intestinal stem cell homeostasisR01CA228346 · NCI · UNIVERSITY OF UTAH · PI RUTTER, JARED P, THUMMEL, CARL S. · 2018 to 2022
$2.3M
NCI NIH HHS R01 CA228346NHLBI NIH HHS T32 HL007576NIGMS NIH HHS R01 GM067945
6 · The paper itself

Abstract

During skeletal muscle regeneration, muscle stem cells (MuSCs) respond to multiple signaling inputs that converge onto mammalian target of rapamycin complex 1 (mTORC1) signaling pathways. mTOR function is essential for establishment of the differentiation-committed progenitors (early stage of differentiation, marked by the induction of

Indexed as

AnimalsCell CommunicationCell DifferentiationCells, CulturedHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1MiceMuscle DevelopmentMuscle Fibers, SkeletalMuscle, SkeletalMyogeninPhosphorylationProtein Serine-Threonine KinasesSatellite Cells, Skeletal MuscleIntracellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1MyogeninPAS domain kinasesProtein Serine-Threonine KinasesmTORmuscle stem cellmyogeninPASKPax7

Identifiers

PMID31072927
PMCPMC6534978
OpenAlexW2943931937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.